VJHemOnc is committed to improving our service to you

COMy 2019 | Update on WM biology and therapy

VJHemOnc is committed to improving our service to you

Steven Treon

Steven Treon, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, reviews the most promising updates in Waldenström’s Macroglobulinemia. Treatment options are expanding in the field with the identification of key targets MYD, CXCR4 and Bcl-2. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter